Effective from
- First observed
Postprocedural endocrine and metabolic complications and disorders, not elsewhere classified
Category — select a more specific code
CDC/NCHS · FY2016For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.
Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.
Official coding guidelines → · CMS ↗First observed · 2015-10-01
No recorded change since first observation
Effective from
Postprocedural endocrine and metabolic complications and disorders, not elsewhere classified
Category — select a more specific code
CDC/NCHS · FY2016| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
E89.0Postprocedural hypothyroidismBillable / specificE89.1Postprocedural hypoinsulinemiaBillable / specificE89.2Postprocedural hypoparathyroidismBillable / specificE89.3Postprocedural hypopituitarismBillable / specificE89.4Postprocedural ovarian failureCategory · further specificity requiredE89.5Postprocedural testicular hypofunctionBillable / specificE89.6Postprocedural adrenocortical (-medullary) hypofunctionBillable / specificE89.8Other postprocedural endocrine and metabolic complications and disordersCategory · further specificity requiredOfficial titles and instructions are preserved in their source language. Official sources ↗
Excludes 2 · postprocedural endocrine and metabolic complications and disorders, not elsewhere classified (E89.-)
Inclusion terms · Conditions in E00-E89
Excludes 2 · intraoperative and postprocedural complications of specific body system (D78.-, E36.-, E89.-, G97.3-, G97.4, H59.3-, H59.-, H95.2-, H95.3, I97.4-, I97.5, J95, K91.-, L76.-, M96.-, N99.-)
Excludes 2 · postprocedural absence of endocrine glands (E89.-)
Excludes 2 · intraoperative and postprocedural complications of specified body systems (D78.-, E36.-, E89.-, G97.3-, G97.4, H59.3-, H59.-, H95.2-, H95.3, I97.4-, I97.5, J95.6-, J95.7, K91.6-, L76.-, M96.-, N99.-)